Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen K Wasan

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 8, 2024
Chitosan non-particulate vaccine delivery systemsRasim Masimov, Ellen K Wasan
Molecular Pharmaceutics|June 3, 2024
Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery ApplicationsSaniya Alwani, Ellen K Wasan, Ildiko Badea
Antimicrobial Agents and Chemotherapy|August 21, 2020
Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle DogsKishor M Wasan, Ellen K Wasan, Peter Hnik
Antimicrobial Agents and Chemotherapy|July 22, 2020
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B AdministrationPeter Hnik, Ellen K Wasan, Kishor M Wasan
Pharmaceutics|March 1, 2019
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?Grace Cuddihy, Ellen K Wasan, Yunyun Di, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 5, 2025
Design-of-experiments based development and in vitro evaluation of a cationic lipid-based triple adjuvanted subunit pertussis vaccineTavonga T Mandava, Volker Gerdts, Maryam Ejlali, et al.
Drug Development and Industrial Pharmacy|August 17, 2018
Scavenger receptor class BI (SR-BI) mediates uptake of CPX-351 into K562 leukemia cellsYunyun Di, Ellen K Wasan, Jacqueline Cawthray, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 3, 2015
Lipid-lowering Activity of Natural and Semi-Synthetic Sterols and StanolsDhiaa A Taha, Ellen K Wasan, Kishor M Wasan, et al.
Pharmaceutics|October 23, 2021
Chitosan Nanoparticles at the Biological Interface: Implications for Drug DeliveryNoorjahan Aibani, Raj Rai, Parth Patel, et al.
Drug Development and Industrial Pharmacy|September 20, 2012
Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to ratsFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 8, 2024
Chitosan non-particulate vaccine delivery systemsRasim Masimov, Ellen K Wasan
Molecular Pharmaceutics|June 3, 2024
Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery ApplicationsSaniya Alwani, Ellen K Wasan, Ildiko Badea
Antimicrobial Agents and Chemotherapy|August 21, 2020
Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle DogsKishor M Wasan, Ellen K Wasan, Peter Hnik
Antimicrobial Agents and Chemotherapy|July 22, 2020
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B AdministrationPeter Hnik, Ellen K Wasan, Kishor M Wasan
Pharmaceutics|March 1, 2019
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?Grace Cuddihy, Ellen K Wasan, Yunyun Di, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 5, 2025
Design-of-experiments based development and in vitro evaluation of a cationic lipid-based triple adjuvanted subunit pertussis vaccineTavonga T Mandava, Volker Gerdts, Maryam Ejlali, et al.
Drug Development and Industrial Pharmacy|August 17, 2018
Scavenger receptor class BI (SR-BI) mediates uptake of CPX-351 into K562 leukemia cellsYunyun Di, Ellen K Wasan, Jacqueline Cawthray, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 3, 2015
Lipid-lowering Activity of Natural and Semi-Synthetic Sterols and StanolsDhiaa A Taha, Ellen K Wasan, Kishor M Wasan, et al.
Pharmaceutics|October 23, 2021
Chitosan Nanoparticles at the Biological Interface: Implications for Drug DeliveryNoorjahan Aibani, Raj Rai, Parth Patel, et al.
Drug Development and Industrial Pharmacy|September 20, 2012
Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to ratsFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
Pageof 4